Michael A Heathman
Overview
Explore the profile of Michael A Heathman including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
4
Citations
84
Followers
0
Related Specialty
Related Specialty
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Aruldhas B, Quinney S, Overholser B, Heathman M, Masters A, Ly R, et al.
CPT Pharmacometrics Syst Pharmacol
. 2021 Aug;
10(10):1183-1194.
PMID: 34435753
Methadone is a synthetic opioid used as an analgesic and for the treatment of opioid abuse disorder. The analgesic dose in the pediatric population is not well-defined. The pharmacokinetics (PKs)...
2.
Geiser J, Heathman M, Cui X, Martin J, Loghin C, Chien J, et al.
Clin Pharmacokinet
. 2015 Oct;
55(5):625-34.
PMID: 26507721
Background And Objective: Dulaglutide is a long-acting glucagon-like peptide-1 receptor agonist administered as once-weekly subcutaneous injections for the treatment of type 2 diabetes (T2D). The clinical pharmacokinetics of dulaglutide were...
3.
Ernest 2nd C, Heathman M, Wrishko R
J Clin Pharmacol
. 2009 Jul;
49(8):973-83.
PMID: 19602721
Prasugrel is a thienopyridine prodrug that is metabolized to an active metabolite (Pras-AM), which inhibits adenosine diphosphate (ADP)-induced platelet aggregation. The study objective was to describe a multilinear regression correlation...
4.
Chien J, Friedrich S, Heathman M, De Alwis D, Sinha V
AAPS J
. 2005 Dec;
7(3):E544-59.
PMID: 16353932
Pharmacokinetic (PK) and pharmacodynamic (PD) modeling and simulation (M&S) are well-recognized powerful tools that enable effective implementation of the learn-and-confirm paradigm in drug development. The impact of PK/PD M&S on...